Melanocortin (MC) Receptors
Read More about this categoryShow Less
Melanocortin receptors (MCRs) comprise a family of five, class A, G protein-coupled receptors designated MC1R-MC5R with diverse physiological roles. MCRs are found in chordates and are regarded as having evolved from a single ancestral receptor, possibly corresponding most closely to MC4R. Signaling by MCRs has primarily been observed as occurring through the stimulatory α unit Gs which activates adenylyl cyclase to produce cAMP.
The central nervous melanocortin system is involved in energy homeostasis, regulating food intake and energy expenditure. The brain melanocortin system is defined as the primary neurons that express neuropeptide ligands, and secondary neurons expressing the predominant neural melanocortin receptors (MC3R, MC4R). Mutations in the gene encoding melanocortin receptor agonists, or the genes encoding MC3R or MC4R cause obesity. The other members of the melanocortin receptor family are primarily expressed in the periphery, and are involved in regulating pigmentation (MC1R), adrenal gland function (MC2R), immune function (MC1R/MC3R), and sebaceous gland activity (MC5R).
Products Related to Melanocortin (MC) Receptors(57)
- GC34002Bremelanotide Acetate (PT-141 Acetate)CAS: 1607799-13-2Purity: >99.00%
Bremelanotide Acetate (PT-141 Acetate) (PT-141 Acetate), a synthetic peptide analogue of α-MSH, is an agonist at melanocortin receptors including the MC3R and MC4R for the treatment of sexual dysfunction.
- GC35254Adrenocorticotropic Hormone (ACTH) (1-39), ratCAS: 77465-10-2Purity: >98%
Adrenocorticotropic Hormone (ACTH) (1-39), rat is a potent melanocortin 2 (MC2) receptor agonist.
- GC35255Adrenocorticotropic Hormone (ACTH) (1-39), rat TFAPurity: >99.50%
Adrenocorticotropic Hormone (ACTH) (1-39), rat (TFA) is a potent melanocortin 2 (MC2) receptor agonist.
- GC36727Neuropeptide EI, ratCAS: 125934-45-4Purity: >98%
Neuropeptide EI, rat displays functional melanin concentrating hormone (MCH)-antagonist and melanocyte-stimulating hormone (MSH) agonist activity in different behavioral paradigms.
- GC36756Nonapeptide-1 acetate saltPurity: >99.50%
Nonapeptide-1 (Melanostatine-5) acetate salt, a peptide hormone, is a selective antagonist of MC1R (Ki: 40 nM).
- GC38107SNT-207858 free baseCAS: 1104662-66-9Purity: >98.00%
SNT207858 free base is a selective, blood brain barrier penetrating, potent and orally active melanocortin-4 (MC-4) receptor antagonist.
- GC64525FenoprofenCAS: 29679-58-1Purity: >99.00%
Fenoprofen (LILLY-53858) is a nonsteroidal anti-inflammatory agent (NSAID).
- GC66383ACTH (11-24) (acetate)Purity: >98.00%
ACTH (11-24) (acetate) is an adrenocorticotropic hormone (ACTH) receptor antagonist. ACTH (11-24) is a fragment of adrenocorticotropic and induces cortisol release. ACTH (11-24) can be used for the research of central nervous system.
- GC68965DersimelagonCAS: 1835256-48-8Purity: >97.00%
Dersimelagon (MT-7117) is a selective melanocortin 1 receptor (MC1R) agonist with oral activity. Its EC50 values for human (h), crab-eating macaque (cm), mouse (m), and rat (r) MC1R are 8.16, 3.91, 1.14, and 0.251 nM respectively. Dersimelagon shows good affinity for hMC1R and hMC4R with Ki values of 2.26 and 32.9 nM respectively. It can be used in research on skin pigmentation [1][2].
- GC69472ML00253764CAS: 681847-92-7Purity: >99.00%
ML00253764 is a selective melanocortin receptor 4 (MC4R) antagonist that induces apoptosis by inhibiting ERK1/2 and Akt phosphorylation, exhibiting anticancer activity.
- GC69813ResomelagonCAS: 1809420-71-0Purity: >98%
Resomelagon (AP1189) is an orally effective melanocortin receptor (MR) agonist, including MC1 and MC3. Resomelagon induces phosphorylation of ERK1/2 and Ca2+ flow. Resomelagon has anti-inflammatory activity. Resomelagon can be used for obesity and chronic inflammation research.
- GC69814Resomelagon acetateCAS: 1809420-72-1Purity: >98%
Resomelagon (AP1189) acetate is an orally effective melanocortin receptor (MR) agonist, including MC1 and MC3. Resomelagon acetate induces ERK1/2 phosphorylation and Ca2+ flux. Resomelagon acetate has anti-inflammatory activity. Resomelagon acetate can be used for obesity and chronic inflammation research.
- GC71028PF-07258669CAS: 2755890-53-8Purity: >98.00%
PF-07258669 is a melanocortin-4 receptor (MC4) antagonist.
- GC72123β-Melanocyte Stimulating Hormone (MSH), human TFAPurity: >99.00%
β-Melanocyte Stimulating Hormone (MSH), human TFA, a 22-residue peptide, acts as an endogenous melanocortin-4 receptor (MC4-R) agonist.
- GC72308TCMCB07 TFAPurity: >99.00%
TCMCB07 TFA, a cyclic nonapeptide peptide, is an orally active and brain-penetrant melanocortin receptor 4 (MC4R) antagonist.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC34002 | Bremelanotide Acetate (PT-141 Acetate) | 1607799-13-2 | >99.00% | |
Bremelanotide Acetate (PT-141 Acetate) (PT-141 Acetate), a synthetic peptide analogue of α-MSH, is an agonist at melanocortin receptors including the MC3R and MC4R for the treatment of sexual dysfunction. | ||||
| GC35244 | ACTH (1-17) TFA | - | >99.00% | |
| GC35254 | Adrenocorticotropic Hormone (ACTH) (1-39), rat | 77465-10-2 | >98% | |
Adrenocorticotropic Hormone (ACTH) (1-39), rat is a potent melanocortin 2 (MC2) receptor agonist. | ||||
| GC35255 | Adrenocorticotropic Hormone (ACTH) (1-39), rat TFA | - | >99.50% | |
Adrenocorticotropic Hormone (ACTH) (1-39), rat (TFA) is a potent melanocortin 2 (MC2) receptor agonist. | ||||
| GC36727 | Neuropeptide EI, rat | 125934-45-4 | >98% | |
Neuropeptide EI, rat displays functional melanin concentrating hormone (MCH)-antagonist and melanocyte-stimulating hormone (MSH) agonist activity in different behavioral paradigms. | ||||
| GC36756 | Nonapeptide-1 acetate salt | - | >99.50% | |
Nonapeptide-1 (Melanostatine-5) acetate salt, a peptide hormone, is a selective antagonist of MC1R (Ki: 40 nM). | ||||
| GC37629 | Setmelanotide TFA | - | >98% | |
| GC38007 | β-Melanocyte Stimulating Hormone (MSH), human TFA | - | >99.50% | |
| GC38107 | SNT-207858 free base | 1104662-66-9 | >98.00% | |
SNT207858 free base is a selective, blood brain barrier penetrating, potent and orally active melanocortin-4 (MC-4) receptor antagonist. | ||||
| GC50303 | MSG 606 | 1416983-77-1 | >98% | |
MSG-606 has potent antagonist activity and receptor selectivity for the human melanocortin 1 receptor (hMC1R) (IC50 = 17 nM) . | ||||
| GC63724 | HS014 TFA | - | >98.50% | |
HS014 TFA is a potent and selective melanocortin MC4 receptor antagonist (K i =3.16nM). | ||||
| GC63756 | PG106 TFA | - | >99.00% | |
PG106 TFA is a potent and selective human melanocortin 3 (hMC3) receptor antagonist (IC50= 210 nM) and has noactivity at?hMC4?receptors (EC50=9900 nM) and?hMC5?receptor. | ||||
| GC63770 | HS024 TFA | - | >99.50% | |
HS024 is a selective MC4 receptor antagonist, with Kis of 0.29, 3.29, 5.45, 18.6 nM for MC4, MC5, MC3, and MC1, respectively. | ||||
| GC64427 | MK-0493 | 455956-93-1 | >98% | |
MK-0493 is a potent, orally active and selective agonist of the melanocortin receptor 4 (MC4R), demonstrating significant reductions in energy intake. | ||||
| GC64525 | Fenoprofen | 29679-58-1 | >99.00% | |
Fenoprofen (LILLY-53858) is a nonsteroidal anti-inflammatory agent (NSAID). | ||||
| GC66383 | ACTH (11-24) (acetate) | - | >98.00% | |
ACTH (11-24) (acetate) is an adrenocorticotropic hormone (ACTH) receptor antagonist. ACTH (11-24) is a fragment of adrenocorticotropic and induces cortisol release. ACTH (11-24) can be used for the research of central nervous system. | ||||
| GC68965 | Dersimelagon | 1835256-48-8 | >97.00% | |
Dersimelagon (MT-7117) is a selective melanocortin 1 receptor (MC1R) agonist with oral activity. Its EC50 values for human (h), crab-eating macaque (cm), mouse (m), and rat (r) MC1R are 8.16, 3.91, 1.14, and 0.251 nM respectively. Dersimelagon shows good affinity for hMC1R and hMC4R with Ki values of 2.26 and 32.9 nM respectively. It can be used in research on skin pigmentation [1][2]. | ||||
| GC69472 | ML00253764 | 681847-92-7 | >99.00% | |
ML00253764 is a selective melanocortin receptor 4 (MC4R) antagonist that induces apoptosis by inhibiting ERK1/2 and Akt phosphorylation, exhibiting anticancer activity. | ||||
| GC69813 | Resomelagon | 1809420-71-0 | >98% | |
Resomelagon (AP1189) is an orally effective melanocortin receptor (MR) agonist, including MC1 and MC3. Resomelagon induces phosphorylation of ERK1/2 and Ca2+ flow. Resomelagon has anti-inflammatory activity. Resomelagon can be used for obesity and chronic inflammation research. | ||||
| GC69814 | Resomelagon acetate | 1809420-72-1 | >98% | |
Resomelagon (AP1189) acetate is an orally effective melanocortin receptor (MR) agonist, including MC1 and MC3. Resomelagon acetate induces ERK1/2 phosphorylation and Ca2+ flux. Resomelagon acetate has anti-inflammatory activity. Resomelagon acetate can be used for obesity and chronic inflammation research. | ||||
| GC71028 | PF-07258669 | 2755890-53-8 | >98.00% | |
PF-07258669 is a melanocortin-4 receptor (MC4) antagonist. | ||||
| GC71439 | CRN04894 | 2392970-97-5 | - | |
CRN04894 (compound 17h) is an orally active MC2R antagonist that demonstrates in vivo efficacy in rat model of adrenocorticotropic hormone (ACTH)-stimulated corticosterone secretion. | ||||
| GC72123 | β-Melanocyte Stimulating Hormone (MSH), human TFA | - | >99.00% | |
β-Melanocyte Stimulating Hormone (MSH), human TFA, a 22-residue peptide, acts as an endogenous melanocortin-4 receptor (MC4-R) agonist. | ||||
| GC72308 | TCMCB07 TFA | - | >99.00% | |
TCMCB07 TFA, a cyclic nonapeptide peptide, is an orally active and brain-penetrant melanocortin receptor 4 (MC4R) antagonist. | ||||
